Two completed studies. Roughly eleven million vaccinated people. No new safety signals. Both already accepted by peer-reviewed journals. Both withdrawn on orders from the US Department of Health and Human Services.
This is not an accident. This is a decision.
Incident 1: The FDA Studies No One Was Meant to See#
The post-market surveillance system for vaccines is not a voluntary program. Congress mandated it after the Vioxx scandal of 2004 — as an institutional response to a known cardiac risk that was concealed for years. The surveillance infrastructure now being quietly dismantled was once the answer to exactly that type of failure.
By October 2025, two completed FDA studies were on file:
- Study A: Approximately seven million Medicare beneficiaries aged 65 and older, 2023/24 season vaccines, multiple safety endpoints.
- Study B: Approximately 4.2 million vaccinated individuals between six months and 64 years of age, 17 health outcomes.
The findings: minimal signals that largely disappeared after standard statistical corrections. Fewer than one additional anaphylaxis case per million Pfizer doses. Fewer than eleven febrile seizures in young children after Moderna. No new significant safety concerns. The results aligned with what international surveillance systems had been publishing since 2023.
Both studies had already been accepted by journals — Drug Safety (Springer) and Vaccine. Then HHS intervened.
HHS spokesperson Andrew Nixon: the authors had drawn “general conclusions that are not supported by the underlying data.” The FDA was acting to “protect the integrity of the scientific process.”
Dr. Jake Scott, Clinical Assistant Professor at Stanford University, writes in a CIDRAP commentary: the withdrawal did not occur because the data were flawed — but because the system worked. It had detected exactly what other global surveillance systems had also documented. That was the problem.
Incident 2: The CDC Study That Was Too Effective#
In April 2026, a second category of unwanted results emerged: efficacy data. A CDC study showed that updated COVID vaccines reduced emergency room visits by approximately 50 percent. It was scheduled to appear in the Morbidity and Mortality Weekly Report — the CDC’s central epidemiological publication, its institutional standard-bearer for decades.
CDC Director Jay Bhattacharya blocked the publication. Reason: methodological concerns. HHS formally rejected the publication on the record.
The methodological objection would be worth examining — if it were applied consistently. It is not. Identical methods continue to be used for influenza vaccine efficacy studies published without objection under Bhattacharya’s leadership. The methodological concerns apply selectively — only where COVID vaccines appear effective.
Bhattacharya was a co-initiator of the 2020 Great Barrington Declaration. He is not a neutral methodologist applying newfound rigor. He is an actor with a documented prior position — and now with authority over what counts as CDC evidence.
The Constellation#
Since early 2025, Robert F. Kennedy Jr. has been HHS Secretary — known for decades of anti-vaccine activism including the long-debunked autism link. Under his leadership: ACIP dissolved, CDC influenza vaccine advertising stopped, all members of the National Science Board dismissed.
These are not isolated decisions. This is the systematic dismantling of the institutional infrastructure that independently documents vaccine safety and efficacy.
The Mechanism and Its Mirror Image#
This is a moment to step back.
In vaccine-critical discourse, a pattern is familiar: a study is cited — selectively, without context, with the suggestion of a connection the data do not support. The signal is extracted from the noise and presented as proof. Inconvenient counterevidence disappears.
What HHS is doing here is structurally identical — only mirrored. Not selective citation, but administrative erasure: the study exists, the result is inconvenient, the study disappears. The rationale — methodological concerns, conclusions unsupported by data — is formally stated but not consistently applied.
Both procedures produce the same result: the public sees only the portion of the evidence base that the respective actor finds acceptable.
This is not a question of vaccine assessment. It is a question of epistemic architecture: who gets to decide which findings may count as real?
What This Means#
The Vioxx-mandated surveillance infrastructure was a promise: safety problems would be systematically documented and published — regardless of whether the results were convenient for industry or for regulators. When HHS withdraws studies that found no safety problems, that promise is broken — not because the agency is concealing risks, but because it is disabling the mechanism for detecting risks in the first place.
A system that may only publish inconvenient results is not a surveillance system. It is a press release.
The Counter-Argument#
HHS argues that the authors overreached their conclusions. When identical methods remain acceptable for influenza vaccine studies while COVID efficacy studies are blocked, that is not a methodological argument — it is the description of a selectivity that demands a different explanation.
The Mechanism and Its Mirror Image#
In vaccine-critical discourse, a pattern is familiar: a study is cited — selectively, without context, with the suggestion of a connection the data do not support. The signal is extracted from the noise and presented as proof. Inconvenient counterevidence disappears.
What HHS is doing here is structurally identical — only mirrored. Not selective citation, but administrative erasure: the study exists, the result is inconvenient, the study disappears. The rationale — methodological concerns, conclusions unsupported by data — is formally stated but not consistently applied.
Both procedures produce the same result: the public sees only the portion of the evidence base that the respective actor finds acceptable.
This is not a question of vaccine assessment. It is a question of epistemic architecture: who gets to decide which findings may count as real?
What This Means#
The Vioxx-mandated surveillance infrastructure was a promise: safety problems would be systematically documented and published — regardless of whether the results were convenient for industry or for regulators. When HHS withdraws studies that found no safety problems, that promise is broken — not because the agency is concealing risks, but because it is disabling the mechanism for detecting risks in the first place.
A system that may only publish inconvenient results is not a surveillance system. It is a press release.
Further reading on elizaonsteroids.org:
- An Inquiry That Pre-Plans Its Conclusions — Germany’s Enquete Commission and its structural design
- Two Outbreaks, One Agency — RKI response to Hondius vs. COVID 2020
